Black men are more likely to be diagnosed with prostate cancer and less likely to receive radical treatment for high-risk cases compared to white men, a new report by the National Prostate Cancer Audit has found.  The National Prostate Cancer Audit (NPCA) State of the Nation Report, published in January 2025, evaluates prostate cancer rates and the care provided to men diagnosed with the disease in England and Wales between 1st Jan 2019 and 31st Dec 2023.  Key ...

A new prostate cancer research update from Practice Update: High Omega-3, Low Omega-6 Fatty Acid Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance - https://www.practiceupdate.com/c/173709/2/1/ The study tested whether a diet high in omega-3s and low in omega-6s, along with fish oil, could slow prostate cancer growth in men with low-risk prostate cancer. Over one year, 100 men were split into two groups: one followed the special diet, and the other ate no...

A new prostate cancer research update from Practice Update: Prebiopsy MRI Oncologically Safe for Suspected Prostate Cancer - https://www.practiceupdate.com/news/48462/2/1This study found that it’s safe for men with suspected prostate cancer to skip a biopsy if their MRI results don’t show any signs of cancer. Researchers monitored these men for three years and found they didn’t have a higher risk of serious prostate cancer compared to those who had a biopsy right...

Great news from The Christie NHS Foundation Trust:The STAMPEDE trial, the world’s largest prostate cancer intervention study with nearly 12,000 participants, has shown that metformin can reduce hormone therapy side effects in advanced prostate cancer treatment.Patients taking metformin alongside standard therapy experienced significantly less weight gain, lower blood sugar levels, and reduced harmful fats compared to those on standard therapy alone.Professor Noel Clarke, a principal i...

Wishing everyone a happy and healthy festive season!

So far we have tested over 450 police personnel from Greater Manchester Police over three testing events!  Pictured, from left to right, Sergeant Damieon Hartley-Pickles (BEM); Chief Constable Stephen Watson; PCS Trustee Phil Ormesher; Deputy Chief Constable Terry Woods; Chief Inspector Danny Atherton (a winner of the Chief Constable’s awards 2022).  Organise health testing for your company - https://tgfct.org.uk/Events/Organising-Corporate-Events PSA Tes...

GFCT are looking to hire a Specialist Stroke or Registered Nurse who would be able to attend our Health Testing events in Warwick on a monthly basis. 17:30 to 20:30 hours, taking clients' blood pressure. For more details, please contact susan@tgfct.org.uk.

Special Discounted Health Testing Event in January! In collaboration with Manchester University who are undertaking a new research project.  If you wish to participate in this study we require you to have 7-8 health tests by GFCT and a general health test (xMOT test) for the research study.  The tests by GFCT are PSA, diabetes, cholesterol, thyroid, kidney function, liver function, vitamin D and iron count. All the tests will be discounted and cost £12.50 each, ins...

At our recent Warwick testing event, we assisted TestCard with the ongoing development of a new type of lateral flow PSA test. From TestCard: "We are very grateful to all the men who volunteered their time for an additional step of a finger prick so that we at TestCard can validate a rapid diagnostic test for PSA that could be used at home. Our test is a lateral flow test, very similar to the Covid antigen tests that everyone has become very familiar with over the last few ye...

Prostate cancer treatment is evolving, with innovative approaches offering new hope to patients seeking effective solutions with fewer side effects. One such advancement is High-Intensity Focused Ultrasound (HIFU)—a minimally invasive focal therapy that targets cancerous prostate tissue while preserving surrounding healthy cells. What is HIFU Therapy? HIFU harnesses the power of highly focused ultrasound waves to heat and destroy cancer cells within the prostate. This precis...